[align=left]Substance [CAS No.]Documentation date:​)
Acrylamide [79-06-1] (2020
TWA: 0.03 mg/m3 (IFV)
STEL: Non
Notations: Skin; DSEN; A2; BEI
MW: 71.08
TLV® Basis: CNS & PNS impair; cancer

BIOLOGICAL EXPOSURE DETERMINANTSAcrylamide [79-06-1] (2022
Determinant: N-(2-Carbamoylethyl)valine (CbEV) in blood
Sampling Time: Not critical
BEI®: 500 pmol/g globin (after 120 days of representative exposure)
Notation: B
Determinant: S-(2-Carbamoylethyl)mercapturic acid (AAMA) in urine
Sampling Time: End